Low dose aspirin does not prevent fibrinolytic response to venous occlusion
- 1 September 1986
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (18) , 3147-3150
- https://doi.org/10.1016/0006-2952(86)90400-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarctionThe American Journal of Cardiology, 1985
- Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.Circulation, 1985
- Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.Stroke, 1985
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- A regimen for low-dose aspirin?BMJ, 1982
- PHARMACOLOGY OF ANTIPLATELET DRUGS AND CLINICAL TRIALS ON THROMBOSIS PREVENTION: A DIFFICULT LINKThe Lancet, 1982
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- The Inhibitory Effect of Aspirin on Platelet and Vascular Prostaglandins in Rats cannot be Completely DissociatedBritish Journal of Haematology, 1979
- Aspirin and Thromboembolism — A Possible DilemmaNew England Journal of Medicine, 1977